Advertisement

Topics

Medi tech Group Company Profile

01:09 EDT 19th June 2018 | BioPortfolio

Medi tech Group, having 2 daughter companies, MD and CMS, founded in 1998, is a group dedicated to provide state-of-the-art products with top-ranking quality and upstanding reputation. As a good provider and professional exporter whose products are sold to all over the world and experiences are abundant and various, we believe that during the days of globalization, facing the conflict of different cultures and customs, the most important thing for running business internationally is to be considerate, modest, creative, steadfast, passional and industrious.

Location

202, 118th Xuzhou Rd
Qingdao
Shandong
China

Contact

Phone: 86-532-85832673
Fax: 86-532-85832155
Email: sales@meditech.cn


News Articles [985 Associated News Articles listed on BioPortfolio]

Beleave (CSE: BE; OTCQX: BLEVF) to Acquire Medi-Green #Cannabis Clinic Network

TORONTO - May 1, 2018 (Investorideas.com Newswire) Beleave Inc. ("Beleave" or the "Company") (CSE: BE; OTCQX: BLEVF) is pleased to announce that it has entered into a definitive agreement to purchase ...

Tech We’re Using: Limiting the Influence of Tech When You Report on It

How Natasha Singer, a tech reporter at The Times, uses tech when she chronicles the industry’s effect on education, privacy and our health.

Living in Digital Times Honors Emerging Tech Gadgets and the Next Generation of Tech Geniuses ...

David Pogue, tech guru and founder of Yahoo! Tech, returned for his third year as emcee and kicked off the event with a witty Read more...

HIV-prevention drug use rises, but is still slow among non-white patients

A report by the California HIV/AIDS Policy Research Centers found the number of PrEP users in Medi-Cal increased from 79 in 2012 to 3,295 in 2016. But the authors also discovered that the use of the

MEDI+SIGN And MVDconnect Announce Dealer Agreement

MVDconnect signs a dealer agreement with MEDI+SIGN to assist hospitals in raising HCAHPS scores, patient satisfaction and patient safety. SMITHSBURG, Md. (PRWEB) January 16, 2018 MEDI+SIGN, a healthc...

Clanwilliam Group acquires NHS tech provider Informatica Systems in global expansion

An NHS technology provider that helps GPs to predict when specific patients are at risk of developing chronic diseases, and that allows planners to track... The post Clanwilliam Group acquires NHS tec...

Imaging Tech Lobby Group Hires New Cybersecurity Chief

In a sign of the times, the Medical Imaging & Technology Alliance, a major medtech trade organization in Washington, DC...   

Apple, Amazon und Alibaba mit Aussicht auf Bonus?

Jewgeni Ponomarev,Zertifikate-Experte,HSBC Während der jüngsten Erholung des S&P 500 waren gerade die Tech-Aktien sehr gefragt. Allerdings ist Tech nicht gleich Tech. Die Geschäftsentwicklung von ....

Drugs and Medications [199 Associated Drugs and Medications listed on BioPortfolio]

Denti-care denti-rinse [AR Medicom Inc]

Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Berry

Denti-care denti-rinse [AR Medicom Inc]

Denti-Care Denti-Rinse 2 % Neutral Sodium Fluoride Oral Rinse Mint

Denti-care denti-freeze [AR Medicom Inc]

Denti-Care Denti-Freeze Topical Anesthetic Gel Strawberry

Denti-care denti-freeze [AR Medicom Inc]

Denti-Care Denti-Freeze Topical Anesthetic Gel Raspberry

Mckesson medi-pak sterile [McKesson Medical-Surgical]

Drug Facts

PubMed Articles [1858 Associated PubMed Articles listed on BioPortfolio]

Morphology-adaptive total variation for the reconstruction of quantitative susceptibility map from the magnetic resonance imaging phase.

Quantitative susceptibility mapping (QSM) is a magnetic resonance imaging technique that quantifies the magnetic susceptibility distribution within biological tissues. QSM calculates the underlying ma...

Quantitative susceptibility mapping using deep neural network: QSMnet.

Deep neural networks have demonstrated promising potential for the field of medical image reconstruction, successfully generating high quality images for CT, PET and MRI. In this work, an MRI reconstr...

Lesbians and tech: Analyzing digital media technologies and lesbian experience.

The rise of the popular Internet has coincided with the increasing acceptance, even assimilation, of lesbians into mainstream society. The visible presence of lesbians in the tech industry and in digi...

Sino-Austrian High-Tech Acupuncture Network: Annual Report 2017.

The Sino-Austrian High-Tech Acupuncture Research Network was founded in 2005 and has been growing ever since. The network comprises many partners from China and is highly involved in research and educ...

Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma.

In the original version of this Article, financial support was not fully acknowledged. The PDF and HTML versions of the Article have now been corrected to include the following: The National Basic Re...

Clinical Trials [3815 Associated Clinical Trials listed on BioPortfolio]

A Study of the Safety and Tolerability of MEDI-570 (Experimental Drug) in Systemic Lupus Erythematosus

The purpose of this study is to evaluate the safety and tolerability of MEDI-570 in adult subjects with moderately to severely active systemic lupus erythematosus (SLE).

Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)

The primary objective of this study is to evaluate the safety and tolerability of intravenously administered MEDI-545 compared with placebo, over a dose escalation range of 0.3-30 mg/kg, i...

Study of MEDI 507 in the Treatment of Pediatric Patients

To assess the safety of escalating dose levels of MEDI-507 in pediatric stem cell and bone marrow allograft recipients who have at least Grade II GvHD.

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528

A Phase I studyto evaluate the safety and tolerability of escalating subcutaneous (SC) doses of MEDI-528 in to healthy adult volunteers.

Companies [2042 Associated Companies listed on BioPortfolio]

Medi tech Group

Medi tech Group, having 2 daughter companies, MD and CMS, founded in 1998, is a group dedicated to provide state-of-the-art products with top-ranking quality and upstanding reputation. As a good provi...

Medi-Span

Medi-Span is the leading provider of drug information for thousands of health care professionals worldwide. With more than 30 years experience, Medi-Span continues to offer author...

The Tech Group, Inc.

The Tech Group is a global leader in injection molding offering contract manufacturing solutions for the medical and consumer industries. Our aggressive and continual investment in technology is our c...

Tech Briefs Media Group

The Tech Briefs Media Group is publisher of NASA Tech Briefs, the largest-circulation design-engineering magazine worldwide and Defense Tech Briefs, the largest-circulation engineering magazine fo...

Finn-Medi Research

Finn-Medi Research was established in 1995 and it is owned by Finnvera, the Hospital District of Pirkanmaa, the Finnish National Fund for Research and Development (SITRA), Finnish Red Cross, City of T...

More Information about "Medi tech Group" on BioPortfolio

We have published hundreds of Medi tech Group news stories on BioPortfolio along with dozens of Medi tech Group Clinical Trials and PubMed Articles about Medi tech Group for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Medi tech Group Companies in our database. You can also find out about relevant Medi tech Group Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record